According to Biomedicine Today, Amgen (AMGN) will provide Temodar, a drug used to treat multiple sclerosis (MS), to India for the first time. MS is the primary supplier of cancer drugs in India, accounting for two thirds of all cancer treatments rendered in the nation. MS is the second-largest source. Along with other biopharma shipments from Amgen's Indian partner Cipla, Novartis, a partner of Amgen, also supplies the MS drug to India. The two large pharmaceutical corporations declared their ambition to work together in 2014.
Facing issue in account approval? email us at info@ipt.pw
Click to Ckeck Our - FREE SEO TOOLS

Loading...
Radhe Exchange ID | Sign up & Register With Us to Get Your Online-ID in Two Minutes
Lords Exchange | Sign up & Register With Us to Get Your Online-ID in Two Minutes
Diamond Exch9 | Sign up & Register With Us to Get Your Online-ID in Two Minutes
Online Stationary Shopping
Freelance Jobs India
Website Hosting in Rs. 99/Year
FREE Dofollow Social Bookmarking Sites
Lords Exchange | Sign up & Register With Us to Get Your Online-ID in Two Minutes
Diamond Exch9 | Sign up & Register With Us to Get Your Online-ID in Two Minutes
Online Stationary Shopping
Freelance Jobs India
Website Hosting in Rs. 99/Year
FREE Dofollow Social Bookmarking Sites
Search
Latest Comments
Log in to comment or register here.